Metraipolis › archive › dc_6ee9cbff1716

Spiky mesoporous silica-based nanovaccines enhance mucosal immunity with improved intestinal retention and antigen accessibility — Europe PMC PMID:42434732

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42434732
DOI
10.1016/j.mtbio.2026.103391
License (as archived)
solo-consultazione
Archived
2026-10-08T15:06:03.126Z
SHA-256 of the archived text
e03c5a1119ebd026b3fdcfea18d5eea2fc6b0492a160bacfd2e5b879bfe6caee
Stable URL of this page
https://metraipolis.com/documento/dc_6ee9cbff1716

How to cite

Spiky mesoporous silica-based nanovaccines enhance mucosal immunity with improved intestinal retention and antigen accessibility — Europe PMC PMID:42434732 — Europe PMC (en), https://europepmc.org/article/MED/42434732 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6ee9cbff1716 (Metraipolis archive dc_6ee9cbff1716, sha256 e03c5a1119ebd026b3fdcfea18d5eea2fc6b0492a160bacfd2e5b879bfe6caee)
BibTeX
@misc{dc6ee9cbff1716,
  title = {Spiky mesoporous silica-based nanovaccines enhance mucosal immunity with improved intestinal retention and antigen accessibility — Europe PMC PMID:42434732},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42434732},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6ee9cbff1716; sha256 e03c5a1119ebd026b3fdcfea18d5eea2fc6b0492a160bacfd2e5b879bfe6caee},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42434732. Agents can read the archived copy with the MCP tool read_document.